BlackRock Health Sciences Trust (BME:NYSE) closed at $45.11 on October 23, 2026, down 0.92% on the day. The stock trades 2.8% below its 52-week high of $46.43 and 20.3% above its 52-week low of $37.51. BlackRock Health Sciences Trust is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, BME closed higher on 127 days (50%). Its best day was October 20, 2026 (+2.71%) and its worst was March 27, 2026 (-3.93%). It never moved 10% or more in a single session.
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Find more stocks like BME with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.